Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico's Proprietary End-to-end Artificial Intelligence Platform

Nov 30, 2021
Robert Marcus

Related news

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Nov 3
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pandemic has caused perfect storm for MedTech

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Predictive language models' underlying function more closely resembles the human brain

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Biden's top science advisor working on AI Bill of Rights

Oct 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The 2021 machine learning, AI, and data landscape

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence In Drug Discovery

Dec 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

390 Startup Failure Post-Mortems

Sep 17
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

China's industrial heartland embraces artificial intelligence

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gartner: 75% of VCs will use AI to make investment decisions by 2025

Nov 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Our Relationship with AI: Friend Or Foe? Summary of our Global Study

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Biden's top science advisor working on AI Bill of Rights

Sep 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report